Investor Overview

KindredBio is a biotechnology company that develops medicines for pets. We believe that our animal family members deserve the same great medicines that human family members enjoy.

Stock Information

NASDAQ CM$8.15
Change (%)0.00 (0.00%)
Volume218,307
Data as of 12/15/17 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.

NEWS

KindredBio Announces Positive Results from Pivotal Study of Zimeta Oral for Fever in Horses

December 4, 2017

SAN FRANCISCO, Dec. 4, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Announces Third Quarter 2017 Financial Results

November 7, 2017

SAN FRANCISCO, Nov. 7, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Announce Third Quarter 2017 Financial Results

October 11, 2017

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...